Cargando…
Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human—Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans-
In the development of drugs, we sometimes encounter fatty change of the hepatocytes (steatosis) which is not accompanied by degenerative change in the liver in non-clinical toxicity studies. In this study, we investigated the relationships between fatty change of the hepatocytes noted in non-clinica...
Autores principales: | Goda, Keisuke, Kobayashi, Akio, Takahashi, Akemi, Takahashi, Tadakazu, Saito, Kosuke, Maekawa, Keiko, Saito, Yoshiro, Sugai, Shoichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412394/ https://www.ncbi.nlm.nih.gov/pubmed/28417920 http://dx.doi.org/10.3390/ijms18040810 |
Ejemplares similares
-
Phosphatidylcholine (18:0/20:4), a potential biomarker to predict ethionamide‐induced hepatic steatosis in rats
por: Muta, Kyotaka, et al.
Publicado: (2022) -
Amiodarone Hepatotoxicity with Absent Phospholipidosis and Steatosis: A Case Report and Review of Amiodarone Toxicity in Various Organs
por: Cimic, Adela, et al.
Publicado: (2013) -
Combined Hepatotoxicity and Toxicity Mechanism of Intermedine and Lycopsamine
por: Wang, Ziqi, et al.
Publicado: (2022) -
Damascenine induced hepatotoxicity and nephrotoxicity in mice and in vitro assessed human erythrocyte toxicity
por: Bouguezza, Yacine, et al.
Publicado: (2015) -
HEPATOTOXICITY OF EUGENOL
por: Soundran, Vijaya, et al.
Publicado: (1994)